additional navigation


You are here:

How does AOP Orphan research and develop?

From an idea to a drug

In the area of medical research, AOP Orphan handles projects at a broad range of different developmental stages: from early clinical trials (phase 1) and multinational registration trials that cover all patients in Europe (phase III) to clinical studies performed with registered medicine with the goal of optimizing administration or placing the medicine at the disposal of other patients.

A worldwide network

AOP Orphan does not own any laboratories, manufacturing facilities or clinics. Instead it relies on a worldwide network of professional service providers to implement its research projects. AOP Orphan is the patent owner of an active pharmaceutical ingredient, which it is currently sponsoring in research projects in order to obtain guidelines and concepts, which it will then pass on to third-party companies.

A highly motivated team of experts

The research team at AOP Orphan covers all essential aspects of a research project: from pre-clinical research to toxicology, pharmaceutical development, clinical development, regulatory affairs, quality management, pharmacovigilance and project management. Experts within each of these specific fields work closely together as project managers and also work with external service providers and partners in the implementation of ambitious development projects.


Products & Area of treatment